SCHEMBL2233554

SCHEMBL2233554

CCC[C@]1(C(=O)c2cccs2)CCNC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 14/20 0.48
SLC6A2 P23975 14/20 0.48
SLC6A4 P31645 14/20 0.48
SLC6A3 Q01959 14/20 0.48
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
HDAC3 O15379 1/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2233561 1.00 CYP2D6 (0.48) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL2233898 0.92 OPRM1 (0.42) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL414945 0.78 SLC6A2 (0.58) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL415150 0.77 CYP2D6 (0.52) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL413046 0.77 SLC6A2 (0.80) CYP2D6SLC6A2SLC6A4SLC6A3HDAC3
SCHEMBL414142 0.77 SLC6A2 (0.80) CYP2D6SLC6A2SLC6A4SLC6A3HDAC3
SCHEMBL415124 0.77 SLC6A2 (0.80) CYP2D6SLC6A2SLC6A4SLC6A3HDAC3
SCHEMBL415165 0.75 CYP2D6 (0.58) CYP2D6SLC6A2SLC6A4SLC6A3ALDH1A1
SCHEMBL415149 0.74 CYP2D6 (0.78) CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL415123 0.74 CYP2D6 (0.78) CYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2354124-A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives F. Hoffmann-La Roche AG (CH) 2011-08-10 EP disclosed